Myeloma Staging System with MRI

Purpose: To stage a patient with multiple myeloma using the Durie Salmon system plus MRI imaging studies.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with multiple myeloma?

Yes

Hemoglobin

Serum calcium

Serum level of monoclonal IgG

Serum level of monoclonal IgA

Urine Bence-Jones protein

g per 24 hours

Number of discrete lesions in spine on MRI

X-ray findings

Diffuse infiltration on MRI

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Stage of multiple myeloma

Median survival in months

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Asymptomatic Multiple Myeloma Model for Predicting Risk of Progression
Other Testing
- Myeloma Staging System
Severity, Prognosis, Stage
- International Staging System for Multiple Myeloma
- Prognostic Groups for Smoldering (Asymptomatic) Multiple Myeloma

Therapy

Selection
- Asymptomatic Multiple Myeloma Model for Predicting Risk of Progression

Monitoring

Response To Therapy
- Criteria for Evaluating Response of Multiple Myeloma to Therapy

Specialty

Hematology Oncology

ICD-10

C90 - Multiple myeloma and malignant plasma cell neoplasms

Info

Purpose: To stage a patient with multiple myeloma using the Durie Salmon system plus MRI imaging studies.

Specialty: Hematology Oncology

ICD-10: C90,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path